UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Williams Companies
WMB
$86.7B
| $132M | 0.13% |
2,262,543
+49,793
| +2% | +$2.31M |
|
|
AGN
177
DELISTED
Allergan plc
AGN
| $129M | 0.13% |
579,139
-22,626
| -4% | -$4.68M |
|
|
STJ
178
DELISTED
St Jude Medical
STJ
| $128M | 0.13% |
1,852,117
-661,790
| -26% | -$42.9M |
|
179
Prologis
PLD
$136B
| $126M | 0.13% |
3,073,363
+204,459
| +7% | +$8.41M |
|
180
Vertex Pharmaceuticals
VRTX
$122B
| $126M | 0.13% |
1,333,117
-37,135
| -3% | -$2.6M |
|
181
Whirlpool
WHR
$2.47B
| $126M | 0.13% |
905,055
-29,477
| -3% | -$4.33M |
|
|
KRFT
182
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $124M | 0.12% |
2,063,114
+20,093
| +1% | +$1.16M |
|
183
Lincoln National
LNC
$8.8B
| $123M | 0.12% |
2,394,192
-238,045
| -9% | -$11.8M |
|
184
Canadian Natural Resources
CNQ
$98.6B
| $123M | 0.12% |
5,525,595
+118,263
| +2% | +$2.37M |
|
185
Exelon
EXC
$46.6B
| $122M | 0.12% |
4,705,286
+218,641
| +5% | +$5.58M |
|
186
Eaton
ETN
$150B
| $122M | 0.12% |
1,584,699
+8,913
| +0.6% | +$661K |
|
187
Bank of Montreal
BMO
$125B
| $121M | 0.12% |
1,646,522
+66,638
| +4% | +$4.65M |
|
188
Corning
GLW
$116B
| $121M | 0.12% |
5,491,944
+476,306
| +9% | +$10.1M |
|
189
Itaú Unibanco
ITUB
$93B
| $120M | 0.12% |
20,843,209
-998,596
| -5% | -$5.88M |
|
190
Becton Dickinson
BDX
$45.6B
| $119M | 0.12% |
1,031,512
-61,504
| -6% | -$6.97M |
|
191
Ecolab
ECL
$78.6B
| $118M | 0.12% |
1,062,068
+10,890
| +1% | +$1.17M |
|
192
PG&E
PCG
$39.2B
| $118M | 0.12% |
2,458,579
+46,862
| +2% | +$2.12M |
|
193
Johnson Controls International
JCI
$87.2B
| $118M | 0.12% |
2,255,734
+2,725
| +0.1% | +$136K |
|
194
Owens Corning
OC
$11.2B
| $117M | 0.12% |
3,034,845
-162,829
| -5% | -$6.69M |
|
195
NOV
NOV
$6.88B
| $117M | 0.12% |
1,425,076
-206,908
| -13% | -$15.4M |
|
196
AvalonBay Communities
AVB
$26.8B
| $117M | 0.12% |
824,348
+73,480
| +10% | +$10.2M |
|
|
AET
197
DELISTED
Aetna Inc
AET
| $116M | 0.12% |
1,429,081
+155,936
| +12% | +$11.8M |
|
|
PARA
198
DELISTED
Paramount Global Class B
PARA
| $115M | 0.12% |
1,855,585
+25,665
| +1% | +$1.53M |
|
|
SE
199
DELISTED
Spectra Energy Corp Wi
SE
| $115M | 0.12% |
2,698,002
+39,463
| +1% | +$1.58M |
|
200
PPG Industries
PPG
$24.9B
| $114M | 0.12% |
1,089,368
-42,624
| -4% | -$4.23M |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.